Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Capricor Therapeutics (CAPR) Shares Outstanding (Weighted Average) (2016 - 2025)

Capricor Therapeutics has reported Shares Outstanding (Weighted Average) over the past 15 years, most recently at $46.5 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Weighted Average) at $46.5 million for Q4 2025, up 841.69% from a year ago — trailing twelve months through Dec 2025 was $46.5 million (up 841.69% YoY), and the annual figure for FY2025 was $46.5 million, up 841.69%.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $46.5 million at Capricor Therapeutics, up from $45.7 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for CAPR hit a ceiling of $46.5 million in Q4 2025 and a floor of $105782.0 in Q4 2021.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $5.0 million (2023), compared with a mean of $15.3 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): tumbled 99.56% in 2023 and later skyrocketed 31181.37% in 2024.
  • Capricor Therapeutics' Shares Outstanding (Weighted Average) stood at $105782.0 in 2021, then changed by 0.0% to $105782.0 in 2022, then skyrocketed by 4665.84% to $5.0 million in 2023, then fell by 2.1% to $4.9 million in 2024, then surged by 841.69% to $46.5 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $46.5 million (Q4 2025), $45.7 million (Q3 2025), and $45.7 million (Q2 2025) per Business Quant data.